Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualization of immunosuppression: concepts and rationale.

Current opinion in organ transplantation - 1 Dec 2008

Wavamunno Moses D, Chapman Jeremy R

Abstract excerpt

PURPOSE OF REVIEW: New immunosuppressive agents have decreased the incidence of acute rejection rates without improvement in long-term outcomes. Drug toxicity due to a narrow therapeutic index and individual variations in pharmacokinetics and pharmacodynamics significantly contributes to the inferior outcomes. This review focuses on advances in individualization of immunosuppression therapy using therapeutic drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcineurin Inhibitors
Share to Drug Dosage Calculations
Share to Drug Monitoring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppression Therapy

Share to Immunosuppressive Agents

Share to Mycophenolic Acid

Share to Organ Transplantation

Share to TOR Serine-Threonine Kinases

Source

Identifiers

PMID: 19060550
DOI: 10.1097/MOT.0b013e3283193bc5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualization of immunosuppression: concepts and rationale.PMID 19060550Read ↗

Recent advances in precision medicine for individualized immunosuppression.Semantic proximity Read ↗

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted PatientsSemantic proximity Read ↗

Personalized immunosuppression after kidney transplantation.Semantic proximity Read ↗

Pharmacogenetics in solid organ transplantation: current status and future directions.Semantic proximity Read ↗

Role of Pharmacogenetics of Immunosuppressive Drugs in Organ TransplantationSemantic proximity Read ↗

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical OverviewSemantic proximity Read ↗

Use of pharmacogenetics to optimize immunosuppressive therapy.Semantic proximity Read ↗

Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations.Semantic proximity Read ↗

The Pharmacogenetics of Calcineurin Inhibitors: One Step Closer Toward Individualized Immunosuppression?Semantic proximity Read ↗

Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.Semantic proximity Read ↗

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapySemantic proximity Read ↗

New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.